$KREF
KKR Real Estate Finance Trust Inc.

2021 Q1 Form 10-Q Financial Statement

#000163159621000027 Filed on April 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $65.92M $69.54M
YoY Change -5.21% 4.26%
Cost Of Revenue $27.38M $39.08M
YoY Change -29.94% 12.17%
Gross Profit $38.54M $30.46M
YoY Change 26.53% -4.39%
Gross Profit Margin 58.46% 43.8%
Selling, General & Admin $9.040M $8.280M
YoY Change 9.18% 22.12%
% of Gross Profit 23.46% 27.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.400M $9.680M
YoY Change -13.22% 27.35%
Operating Profit $30.14M $20.78M
YoY Change 45.04% -14.34%
Interest Expense $27.38M $39.08M
YoY Change -29.93% 12.17%
% of Operating Profit 90.85% 188.08%
Other Income/Expense, Net $1.156M -$1.541M
YoY Change -175.02% -179.07%
Pretax Income $30.14M -$34.49M
YoY Change -187.39% -242.19%
Income Tax $48.00K $82.00K
% Of Pretax Income 0.16%
Net Earnings $30.09M -$34.57M
YoY Change -187.04% -242.58%
Net Earnings / Revenue 45.65% -49.72%
Basic Earnings Per Share $0.52 -$0.61
Diluted Earnings Per Share $0.52 -$0.61
COMMON SHARES
Basic Shares Outstanding 55.62M shares 57.35M shares
Diluted Shares Outstanding 55.73M shares 57.35M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $209.3M $369.9M
YoY Change -43.42% 61.95%
Cash & Equivalents $209.3M $369.9M
Short-Term Investments
Other Short-Term Assets $200.0K
YoY Change
Inventory
Prepaid Expenses
Receivables $16.50M $17.30M
Other Receivables $0.00 $0.00
Total Short-Term Assets $226.0M $387.2M
YoY Change -41.63% 58.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $33.60M $34.40M
YoY Change -2.33% 5.2%
Other Assets $2.300M $3.100M
YoY Change -25.81%
Total Long-Term Assets $5.047B $5.068B
YoY Change -0.43% 4.5%
TOTAL ASSETS
Total Short-Term Assets $226.0M $387.2M
Total Long-Term Assets $5.047B $5.068B
Total Assets $5.273B $5.456B
YoY Change -3.35% 7.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $700.0K $5.400M
YoY Change -87.04% 25.58%
Accrued Expenses $11.10M $11.00M
YoY Change 0.91% -99.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.00M $45.60M
YoY Change -10.09% -96.07%
LONG-TERM LIABILITIES
Long-Term Debt $4.179B $4.378B
YoY Change -4.55% 56.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.179B $4.378B
YoY Change -4.55% 56.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.00M $45.60M
Total Long-Term Liabilities $4.179B $4.378B
Total Liabilities $4.220B $4.423B
YoY Change -4.61% 11.61%
SHAREHOLDERS EQUITY
Retained Earnings -$60.43M -$8.594M
YoY Change 603.16% 2958.36%
Common Stock $556.0K $575.0K
YoY Change -3.3% 0.17%
Preferred Stock
YoY Change
Treasury Stock (at cost) $61.00M $55.20M
YoY Change 10.5% 53.52%
Treasury Stock Shares
Shareholders Equity $1.051B $1.030B
YoY Change
Total Liabilities & Shareholders Equity $5.273B $5.456B
YoY Change -3.35% 7.1%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $30.09M -$34.57M
YoY Change -187.04% -242.58%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $30.27M $27.38M
YoY Change 10.56% 6.89%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$201.2M -$154.6M
YoY Change 30.14% -165.37%
Cash From Investing Activities -$201.2M -$154.6M
YoY Change 30.17% -165.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $23.25M
YoY Change -100.0% 466.29%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $269.5M $429.5M
YoY Change -37.25% -457.27%
NET CHANGE
Cash From Operating Activities $30.27M $27.38M
Cash From Investing Activities -$201.2M -$154.6M
Cash From Financing Activities $269.5M $429.5M
Net Change In Cash $98.52M $302.2M
YoY Change -67.41% 112.99%
FREE CASH FLOW
Cash From Operating Activities $30.27M $27.38M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001631596
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-38082
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
KKR Real Estate Finance Trust Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2009094
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
30 Hudson Yards,
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 7500
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
140806000 USD
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
CY2021Q1 dei City Area Code
CityAreaCode
212
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
750-8300
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55619428 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
209347000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110832000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
5026920000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
4844534000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
58473000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
59801000 USD
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
4968447000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
4784733000 USD
CY2021Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
33624000 USD
CY2020Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
33651000 USD
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
16513000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
15412000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
44949000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
20984000 USD
CY2021Q1 us-gaap Assets
Assets
5272880000 USD
CY2020Q4 us-gaap Assets
Assets
4965612000 USD
CY2021Q1 us-gaap Line Of Credit
LineOfCredit
2876743000 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
2574747000 USD
CY2021Q1 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
807000000 USD
CY2020Q4 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
810000000 USD
CY2021Q1 us-gaap Secured Debt
SecuredDebt
287720000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
288028000 USD
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
140465000 USD
CY2021Q1 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
66237000 USD
CY2020Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
66232000 USD
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
24119000 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
24287000 USD
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7868000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5381000 USD
CY2021Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
4516000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
6243000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
4493000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
4823000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
4219502000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3920206000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
2562000 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
1852000 USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55619428 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55619428 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55619428 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55619428 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
556000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
556000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1171689000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1169695000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60430000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65698000 USD
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3900326 shares
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3900326 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
60999000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
60999000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1050816000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1043554000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1050816000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1043554000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5272880000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4965612000 USD
CY2021Q1 us-gaap Settlement Assets Current
SettlementAssetsCurrent
40000000.0 USD
CY2020Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
15900000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
600000 USD
CY2020Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
900000 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
64766000 USD
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
71079000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
27383000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
39082000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
37383000 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
31997000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1090000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1901000 USD
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
66000 USD
CY2020Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
360000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1156000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1541000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3505000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3767000 USD
CY2021Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1588000 USD
CY2020Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
55274000 USD
CY2021Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
4290000 USD
CY2020Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
4299000 USD
CY2021Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
2192000 USD
CY2020Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
1606000 USD
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8399000 USD
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
64946000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30140000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34490000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
30092000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-34572000 USD
CY2021Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
908000 USD
CY2020Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
592000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29184000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35164000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55619428 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57346726 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55731061 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57346726 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q1 us-gaap Profit Loss
ProfitLoss
30092000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-34572000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3660000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5388000 USD
CY2021Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
4460000 USD
CY2020Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
4333000 USD
CY2021Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
845000 USD
CY2020Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
0 USD
CY2021Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
288000 USD
CY2020Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
-2789000 USD
CY2021Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1588000 USD
CY2020Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
55274000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1994000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1607000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1101000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
958000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-82000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
687000 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2487000 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
827000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
246000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1895000 USD
CY2021Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-11000 USD
CY2020Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
146000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30268000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27376000 USD
CY2021Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
370566000 USD
CY2020Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
179553000 USD
CY2021Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
571796000 USD
CY2020Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
334146000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-201230000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154593000 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
718112000 USD
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
805967000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
23916000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24719000 USD
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
366000 USD
CY2020Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
303000 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
422096000 USD
CY2020Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
324825000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
433000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2206000 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
104000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
157000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
23252000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1720000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1040000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
269477000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
429465000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
98515000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
302248000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110832000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67619000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209347000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
369867000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
20561000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
33376000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q1 kref Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
40000000 USD
CY2020Q1 kref Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
0 USD
CY2021Q1 us-gaap Dividends
Dividends
24119000 USD
CY2020Q1 us-gaap Dividends
Dividends
24204000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— The preparation of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes subjective estimates to project cash flows KREF expects to receive on its investments in loans and securities as well as the related market discount rates, which significantly impacts the interest income, impairments, allowance for loan loss and fair values recorded or disclosed. The effects of COVID-19 may negatively and materially impact significant estimates and assumptions used by the Company including, but not limited to estimates of expected credit losses, valuation of our equity method investments and the fair value estimates of the Company’s assets and liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual results could materially differ from those estimates.</span>
CY2021Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
2600000 USD
CY2021Q1 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
46900000 USD
CY2020Q4 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
42600000 USD
CY2021Q1 us-gaap Settlement Assets Current
SettlementAssetsCurrent
40000000.0 USD
CY2021Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
200000 USD
CY2020Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
15900000 USD
CY2020Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
500000 USD
CY2021Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3200000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
600000 USD
CY2021Q1 us-gaap Deposits
Deposits
600000 USD
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3100000 USD
CY2020Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
900000 USD
CY2020Q4 us-gaap Deposits
Deposits
800000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
2600000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
115100000 USD
CY2020Q1 kref Net Accelerated Fees
NetAcceleratedFees
200000 USD
CY2021Q1 kref Net Accelerated Fees
NetAcceleratedFees
1000000.0 USD
CY2021Q1 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
3.1
CY2020Q4 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
3.1
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5600000 USD
CY2021Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.343
CY2020Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.367
CY2021Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.318
CY2020Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.348
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
804564000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1393466000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
460734000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
222326000 USD
CY2021Q1 kref Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
0 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2881090000 USD
CY2021Q1 kref Debt Instrument Covenant Interest Incometo Interest Expense Ratio
DebtInstrumentCovenantInterestIncometoInterestExpenseRatio
1.5
CY2021Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Minimum Percentageof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthMinimumPercentageofAggregateCashProceedsMadeandCapitalContributionsReceived
0.750
CY2021Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Amountof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthAmountofAggregateCashProceedsMadeandCapitalContributionsReceived
880200000 USD
CY2021Q1 kref Debt Instrument Covenant Cash Liquidity Amount
DebtInstrumentCovenantCashLiquidityAmount
10000000.0 USD
CY2021Q1 kref Debt Instrument Covenant Cash Liquidity Percentof Recourse Indebtedness
DebtInstrumentCovenantCashLiquidityPercentofRecourseIndebtedness
0.050
CY2021Q1 kref Debt Instrument Covenant Total Indebtedness Percentof Total Assets
DebtInstrumentCovenantTotalIndebtednessPercentofTotalAssets
0.750
CY2020Q3 kref Debt Instrument Covenant Senior Recourse Debt Percent Of Total Assets
DebtInstrumentCovenantSeniorRecourseDebtPercentOfTotalAssets
0.80
CY2020Q3 kref Debt Instrument Covenant Recourse Debt Percent Of Total Assets
DebtInstrumentCovenantRecourseDebtPercentOfTotalAssets
0.82
CY2018Q4 kref Collateralized Loan Obligations Reinvestment Feature Term
CollateralizedLoanObligationsReinvestmentFeatureTerm
P2Y
CY2018Q4 kref Collateralized Loan Obligations Reinvestment Feature Term
CollateralizedLoanObligationsReinvestmentFeatureTerm
P2Y
CY2021Q1 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.189
CY2020Q4 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.205
CY2020Q4 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2021Q1 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2021Q1 us-gaap Settlement Assets Current
SettlementAssetsCurrent
40000000.0 USD
CY2021Q1 kref Number Of Equity Method Investments
NumberOfEquityMethodInvestments
2 investment
CY2014Q4 kref Common Stockand Preferred Stock Shares Authorized
CommonStockandPreferredStockSharesAuthorized
350000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55619428 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55619428 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55619428 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55619428 shares
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3900326 shares
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3900326 shares
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1648551 shares
CY2020Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
11.64
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19200000 USD
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2037637 shares
CY2020 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
12.27
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25000000.0 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
23916000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
23916000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24010000 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24010000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29184000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35164000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55619428 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57346726 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
111633 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55731061 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57346726 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2021Q1 kref Sharebased Compensation Arrangementby Sharebased Payment Award Issuance Ratio
SharebasedCompensationArrangementbySharebasedPaymentAwardIssuanceRatio
1
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2021Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
4516000 USD
CY2020Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
6243000 USD
CY2021Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6834000 USD
CY2020Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6204000 USD
CY2020Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
20500000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD

Files In Submission

Name View Source Status
0001631596-21-000027-index-headers.html Edgar Link pending
0001631596-21-000027-index.html Edgar Link pending
0001631596-21-000027.txt Edgar Link pending
0001631596-21-000027-xbrl.zip Edgar Link pending
a202103-exhibit101.htm Edgar Link pending
a202103-exhibit311.htm Edgar Link pending
a202103-exhibit312.htm Edgar Link pending
a202103-exhibit321.htm Edgar Link pending
a202103-exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kref-20210331.htm Edgar Link pending
kref-20210331.xsd Edgar Link pending
kref-20210331_cal.xml Edgar Link unprocessable
kref-20210331_def.xml Edgar Link unprocessable
kref-20210331_g1.jpg Edgar Link pending
kref-20210331_g2.jpg Edgar Link pending
kref-20210331_htm.xml Edgar Link completed
kref-20210331_lab.xml Edgar Link unprocessable
kref-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending